APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drug Delivery Devices

Drug delivery devices are used to delivery drug to the specific part of body or cure some disease. With the help of drug delivery devices, drug can efficiently reach the target and be in a controlled manner. Generally, there are several of drug delivery devices corresponding to the medicine taken ways, such as syringe, spray bottle and implantable drug delivery devices etc.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Drug delivery devices are used to delivery drug to the specific part of body or cure some disease. With the help of drug delivery devices, drug can efficiently reach the target and be in a controlled manner. Generally, there are several of drug delivery devices corresponding to the medicine taken ways, such as syringe, spray bottle and implantable drug delivery devices etc.

Selected research

Market Outlook & Growth Opportunities

Global Drug Delivery Devices Market Outlook and Growth Opportunities 2026

25 December 2025211 pages

Choose your research edition.

Industry ResearchDrug Delivery Devices Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Drug Delivery Devices Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Drug Delivery Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drug Delivery Devices Market Outlook and Growth Opportunities 2026211 pages · $4,250 USDMarket Analysis & ForecastGlobal Drug Delivery Devices Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

Drug delivery devices are used to delivery drug to the specific part of body or cure some disease. With the help of drug delivery devices, drug can efficiently reach the target and be in a controlled manner. Generally, there are several of drug delivery devices corresponding to the medicine taken ways, such as syringe, spray bottle and implantable drug delivery devices etc.

The top five global manufacturers of drug delivery equipment are Cipla, Baxter International, Nipro Corporation, Roche and Boehringer Ingelheim, with a combined market share of 29 per cent. North America, which has a well-established healthcare infrastructure and a large number of leading pharmaceutical and biopharmaceutical companies (around 80% of the world's research and development in biopharmaceutical is conducted by US-based firms), is the largest market for drug delivery, about for 47% followed by Europe with 28%.

This report provides an overview of the global Drug Delivery Devices market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Drug Delivery Devices and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Drug Delivery Devices revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Drug Delivery Devices market.

Drug Delivery Devices Segment by Company

Cipla

Baxter International

Nipro Corporation

Roche

Boehringer Ingelheim

Allergan

3M

BD

Catalent

Valeant Pharmaceuticals

Bayer AG

Chiesi

Phillips-Medisize

Johnson & Johnson

Shandong Weigao

Pfizer

B.Braun

Novartis AG

Zhengkang

Gerresheimer

COVIDIEN Medtronic

Schott forma vitrum

Alkermes

Skyepharma

Drug Delivery Devices Segment by Type

Injection Type

Mucosal Type

Implanted Type

Others Type

Drug Delivery Devices Segment by Application

Pharmaceutical Companies

Hospitals

Clinics

Other

Drug Delivery Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Drug Delivery Devices status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Drug Delivery Devices key companies, revenue, market share, and recent developments.

3. To split the Drug Delivery Devices breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Drug Delivery Devices market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Drug Delivery Devices significant trends, drivers, influence factors in global and regions.

6. To analyze Drug Delivery Devices competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Delivery Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug Delivery Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Delivery Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Drug Delivery Devices industry.

Chapter 3: Detailed analysis of Drug Delivery Devices company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Drug Delivery Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Drug Delivery Devices in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Drug Delivery Devices Industry Trends Table 2. Drug Delivery Devices Industry Drivers Table 3. Drug Delivery Devices Industry Opportunities and Challenges Table 4. Drug Delivery Devices Industry Restraints Table 5. Global Drug Delivery Devices Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Drug Delivery Devices Revenue Share by Company (2021-2026) Table 7. Global Drug Delivery Devices Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Drug Delivery Devices Key Company Manufacturing Base & Headquarters Table 9. Global Drug Delivery Devices Company, Product Type & Application Table 10. Global Drug Delivery Devices Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Drug Delivery Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Injection Type Table 15. Significant Companies of Mucosal Type Table 16. Significant Companies of Implanted Type Table 17. Significant Companies of Others Type Table 18. Global Drug Delivery Devices Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Drug Delivery Devices Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Drug Delivery Devices Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Drug Delivery Devices Sales Value Share by Type (2021-2026) Table 22. Global Drug Delivery Devices Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Pharmaceutical Companies Table 24. Significant Companies of Hospitals Table 25. Significant Companies of Clinics Table 26. Significant Companies of Other Table 27. Global Drug Delivery Devices Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Drug Delivery Devices Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Drug Delivery Devices Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Drug Delivery Devices Sales Value Share by Application (2021-2026) Table 31. Global Drug Delivery Devices Sales Value Share by Application (2027-2032) Table 32. Global Drug Delivery Devices Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Drug Delivery Devices Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Drug Delivery Devices Sales Value Share by Region (2021-2026) Table 35. Global Drug Delivery Devices Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Drug Delivery Devices Sales Value Share by Region (2027-2032) Table 37. Global Drug Delivery Devices Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Drug Delivery Devices Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Drug Delivery Devices Sales Value Market Share by Country (2021-2026) Table 40. Global Drug Delivery Devices Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Drug Delivery Devices Sales Value Market Share by Country (2027-2032) Table 42. Cipla Company Information Table 43. Cipla Business Overview Table 44. Cipla Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Cipla Drug Delivery Devices Product Portfolio Table 46. Cipla Recent Development Table 47. Baxter International Company Information Table 48. Baxter International Business Overview Table 49. Baxter International Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Baxter International Drug Delivery Devices Product Portfolio Table 51. Baxter International Recent Development Table 52. Nipro Corporation Company Information Table 53. Nipro Corporation Business Overview Table 54. Nipro Corporation Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Nipro Corporation Drug Delivery Devices Product Portfolio Table 56. Nipro Corporation Recent Development Table 57. Roche Company Information Table 58. Roche Business Overview Table 59. Roche Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Roche Drug Delivery Devices Product Portfolio Table 61. Roche Recent Development Table 62. Boehringer Ingelheim Company Information Table 63. Boehringer Ingelheim Business Overview Table 64. Boehringer Ingelheim Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Boehringer Ingelheim Drug Delivery Devices Product Portfolio Table 66. Boehringer Ingelheim Recent Development Table 67. Allergan Company Information Table 68. Allergan Business Overview Table 69. Allergan Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Allergan Drug Delivery Devices Product Portfolio Table 71. Allergan Recent Development Table 72. 3M Company Information Table 73. 3M Business Overview Table 74. 3M Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. 3M Drug Delivery Devices Product Portfolio Table 76. 3M Recent Development Table 77. BD Company Information Table 78. BD Business Overview Table 79. BD Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. BD Drug Delivery Devices Product Portfolio Table 81. BD Recent Development Table 82. Catalent Company Information Table 83. Catalent Business Overview Table 84. Catalent Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Catalent Drug Delivery Devices Product Portfolio Table 86. Catalent Recent Development Table 87. Valeant Pharmaceuticals Company Information Table 88. Valeant Pharmaceuticals Business Overview Table 89. Valeant Pharmaceuticals Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Valeant Pharmaceuticals Drug Delivery Devices Product Portfolio Table 91. Valeant Pharmaceuticals Recent Development Table 92. Bayer AG Company Information Table 93. Bayer AG Business Overview Table 94. Bayer AG Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 95. Bayer AG Drug Delivery Devices Product Portfolio Table 96. Bayer AG Recent Development Table 97. Chiesi Company Information Table 98. Chiesi Business Overview Table 99. Chiesi Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 100. Chiesi Drug Delivery Devices Product Portfolio Table 101. Chiesi Recent Development Table 102. Phillips-Medisize Company Information Table 103. Phillips-Medisize Business Overview Table 104. Phillips-Medisize Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 105. Phillips-Medisize Drug Delivery Devices Product Portfolio Table 106. Phillips-Medisize Recent Development Table 107. Johnson & Johnson Company Information Table 108. Johnson & Johnson Business Overview Table 109. Johnson & Johnson Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 110. Johnson & Johnson Drug Delivery Devices Product Portfolio Table 111. Johnson & Johnson Recent Development Table 112. Shandong Weigao Company Information Table 113. Shandong Weigao Business Overview Table 114. Shandong Weigao Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 115. Shandong Weigao Drug Delivery Devices Product Portfolio Table 116. Shandong Weigao Recent Development Table 117. Pfizer Company Information Table 118. Pfizer Business Overview Table 119. Pfizer Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 120. Pfizer Drug Delivery Devices Product Portfolio Table 121. Pfizer Recent Development Table 122. B.Braun Company Information Table 123. B.Braun Business Overview Table 124. B.Braun Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 125. B.Braun Drug Delivery Devices Product Portfolio Table 126. B.Braun Recent Development Table 127. Novartis AG Company Information Table 128. Novartis AG Business Overview Table 129. Novartis AG Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 130. Novartis AG Drug Delivery Devices Product Portfolio Table 131. Novartis AG Recent Development Table 132. Zhengkang Company Information Table 133. Zhengkang Business Overview Table 134. Zhengkang Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 135. Zhengkang Drug Delivery Devices Product Portfolio Table 136. Zhengkang Recent Development Table 137. Gerresheimer Company Information Table 138. Gerresheimer Business Overview Table 139. Gerresheimer Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 140. Gerresheimer Drug Delivery Devices Product Portfolio Table 141. Gerresheimer Recent Development Table 142. COVIDIEN Medtronic Company Information Table 143. COVIDIEN Medtronic Business Overview Table 144. COVIDIEN Medtronic Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 145. COVIDIEN Medtronic Drug Delivery Devices Product Portfolio Table 146. COVIDIEN Medtronic Recent Development Table 147. Schott forma vitrum Company Information Table 148. Schott forma vitrum Business Overview Table 149. Schott forma vitrum Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 150. Schott forma vitrum Drug Delivery Devices Product Portfolio Table 151. Schott forma vitrum Recent Development Table 152. Alkermes Company Information Table 153. Alkermes Business Overview Table 154. Alkermes Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 155. Alkermes Drug Delivery Devices Product Portfolio Table 156. Alkermes Recent Development Table 157. Skyepharma Company Information Table 158. Skyepharma Business Overview Table 159. Skyepharma Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 160. Skyepharma Drug Delivery Devices Product Portfolio Table 161. Skyepharma Recent Development Table 162. Research Programs/Design for This Report Table 163. Authors List of This Report Table 164. Secondary Sources Table 165. Primary Sources List of Figures Figure 1. Drug Delivery Devices Product Image Figure 2. Global Drug Delivery Devices Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drug Delivery Devices Market Size (2021-2032) & (US$ Million) Figure 4. Global Drug Delivery Devices Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Injection Type Image Figure 8. Mucosal Type Image Figure 9. Implanted Type Image Figure 10. Others Type Image Figure 11. Global Drug Delivery Devices Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Drug Delivery Devices Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Drug Delivery Devices Sales Value Share by Type (2021-2032) Figure 14. Pharmaceutical Companies Image Figure 15. Hospitals Image Figure 16. Clinics Image Figure 17. Other Image Figure 18. Global Drug Delivery Devices Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Drug Delivery Devices Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Drug Delivery Devices Sales Value Share by Application (2021-2032) Figure 21. Global Drug Delivery Devices Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Drug Delivery Devices Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Drug Delivery Devices Sales Value (2021-2032) & (US$ Million) Figure 24. North America Drug Delivery Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Drug Delivery Devices Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Drug Delivery Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Drug Delivery Devices Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Drug Delivery Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Drug Delivery Devices Sales Value (2021-2032) & (US$ Million) Figure 30. South America Drug Delivery Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Drug Delivery Devices Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Drug Delivery Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Drug Delivery Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Injection Type
  • Mucosal Type
  • Implanted Type
  • Others Type
Applications
  • Pharmaceutical Companies
  • Hospitals
  • Clinics
  • Other
Companies covered
  • Cipla
  • Baxter International
  • Nipro Corporation
  • Roche
  • Boehringer Ingelheim
  • Allergan
  • 3M
  • BD
  • Catalent
  • Valeant Pharmaceuticals
  • Bayer AG
  • Chiesi
  • Phillips-Medisize
  • Johnson & Johnson
  • Shandong Weigao
  • Pfizer
  • B.Braun
  • Novartis AG
  • Zhengkang
  • Gerresheimer
  • COVIDIEN Medtronic
  • Schott forma vitrum
  • Alkermes
  • Skyepharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Drug Delivery Devices Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Drug Delivery Devices Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Drug Delivery Devices Market Dynamics
  1. 2.1 Drug Delivery Devices Industry Trends
  2. 2.2 Drug Delivery Devices Industry Drivers
  3. 2.3 Drug Delivery Devices Industry Opportunities and Challenges
  4. 2.4 Drug Delivery Devices Industry Restraints
3 Drug Delivery Devices Market by Company
  1. 3.1 Global Drug Delivery Devices Company Revenue Ranking in 2025
  2. 3.2 Global Drug Delivery Devices Revenue by Company (2021-2026)
  3. 3.3 Global Drug Delivery Devices Company Ranking (2024-2026)
  4. 3.4 Global Drug Delivery Devices Company Manufacturing Base and Headquarters
  5. 3.5 Global Drug Delivery Devices Company Product Type and Application
  6. 3.6 Global Drug Delivery Devices Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Drug Delivery Devices Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Drug Delivery Devices Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Drug Delivery Devices Market by Type
  1. 4.1 Drug Delivery Devices Type Introduction
  2. 4.1.1 Injection Type
  3. 4.1.2 Mucosal Type
  4. 4.1.3 Implanted Type
  5. 4.1.4 Others Type
  6. 4.2 Global Drug Delivery Devices Sales Value by Type
  7. 4.2.1 Global Drug Delivery Devices Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Drug Delivery Devices Sales Value by Type (2021-2032)
  9. 4.2.3 Global Drug Delivery Devices Sales Value Share by Type (2021-2032)
5 Drug Delivery Devices Market by Application
  1. 5.1 Drug Delivery Devices Application Introduction
  2. 5.1.1 Pharmaceutical Companies
  3. 5.1.2 Hospitals
  4. 5.1.3 Clinics
  5. 5.1.4 Other
  6. 5.2 Global Drug Delivery Devices Sales Value by Application
  7. 5.2.1 Global Drug Delivery Devices Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Drug Delivery Devices Sales Value by Application (2021-2032)
  9. 5.2.3 Global Drug Delivery Devices Sales Value Share by Application (2021-2032)
6 Drug Delivery Devices Regional Value Analysis
  1. 6.1 Global Drug Delivery Devices Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Drug Delivery Devices Sales Value by Region (2021-2032)
  3. 6.2.1 Global Drug Delivery Devices Sales Value by Region: 2021-2026
  4. 6.2.2 Global Drug Delivery Devices Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Drug Delivery Devices Sales Value (2021-2032)
  7. 6.3.2 North America Drug Delivery Devices Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Drug Delivery Devices Sales Value (2021-2032)
  10. 6.4.2 Europe Drug Delivery Devices Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Drug Delivery Devices Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Drug Delivery Devices Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Drug Delivery Devices Sales Value (2021-2032)
  16. 6.6.2 South America Drug Delivery Devices Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Drug Delivery Devices Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Drug Delivery Devices Sales Value Share by Country, 2025 VS 2032
7 Drug Delivery Devices Country-level Value Analysis
  1. 7.1 Global Drug Delivery Devices Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Drug Delivery Devices Sales Value by Country (2021-2032)
  3. 7.2.1 Global Drug Delivery Devices Sales Value by Country (2021-2026)
  4. 7.2.2 Global Drug Delivery Devices Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Drug Delivery Devices Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Drug Delivery Devices Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Drug Delivery Devices Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Cipla
  2. 8.1.1 Cipla Company Information
  3. 8.1.2 Cipla Business Overview
  4. 8.1.3 Cipla Drug Delivery Devices Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Cipla Drug Delivery Devices Product Portfolio
  6. 8.1.5 Cipla Recent Developments
  7. 8.2 Baxter International
  8. 8.2.1 Baxter International Company Information
  9. 8.2.2 Baxter International Business Overview
  10. 8.2.3 Baxter International Drug Delivery Devices Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Baxter International Drug Delivery Devices Product Portfolio
  12. 8.2.5 Baxter International Recent Developments
  13. 8.3 Nipro Corporation
  14. 8.3.1 Nipro Corporation Company Information
  15. 8.3.2 Nipro Corporation Business Overview
  16. 8.3.3 Nipro Corporation Drug Delivery Devices Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Nipro Corporation Drug Delivery Devices Product Portfolio
  18. 8.3.5 Nipro Corporation Recent Developments
  19. 8.4 Roche
  20. 8.4.1 Roche Company Information
  21. 8.4.2 Roche Business Overview
  22. 8.4.3 Roche Drug Delivery Devices Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Roche Drug Delivery Devices Product Portfolio
  24. 8.4.5 Roche Recent Developments
  25. 8.5 Boehringer Ingelheim
  26. 8.5.1 Boehringer Ingelheim Company Information
  27. 8.5.2 Boehringer Ingelheim Business Overview
  28. 8.5.3 Boehringer Ingelheim Drug Delivery Devices Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Boehringer Ingelheim Drug Delivery Devices Product Portfolio
  30. 8.5.5 Boehringer Ingelheim Recent Developments
  31. 8.6 Allergan
  32. 8.6.1 Allergan Company Information
  33. 8.6.2 Allergan Business Overview
  34. 8.6.3 Allergan Drug Delivery Devices Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Allergan Drug Delivery Devices Product Portfolio
  36. 8.6.5 Allergan Recent Developments
  37. 8.7 3M
  38. 8.7.1 3M Company Information
  39. 8.7.2 3M Business Overview
  40. 8.7.3 3M Drug Delivery Devices Revenue and Gross Margin (2021-2026)
  41. 8.7.4 3M Drug Delivery Devices Product Portfolio
  42. 8.7.5 3M Recent Developments
  43. 8.8 BD
  44. 8.8.1 BD Company Information
  45. 8.8.2 BD Business Overview
  46. 8.8.3 BD Drug Delivery Devices Revenue and Gross Margin (2021-2026)
  47. 8.8.4 BD Drug Delivery Devices Product Portfolio
  48. 8.8.5 BD Recent Developments
  49. 8.9 Catalent
  50. 8.9.1 Catalent Company Information
  51. 8.9.2 Catalent Business Overview
  52. 8.9.3 Catalent Drug Delivery Devices Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Catalent Drug Delivery Devices Product Portfolio
  54. 8.9.5 Catalent Recent Developments
  55. 8.10 Valeant Pharmaceuticals
  56. 8.10.1 Valeant Pharmaceuticals Company Information
  57. 8.10.2 Valeant Pharmaceuticals Business Overview
  58. 8.10.3 Valeant Pharmaceuticals Drug Delivery Devices Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Valeant Pharmaceuticals Drug Delivery Devices Product Portfolio
  60. 8.10.5 Valeant Pharmaceuticals Recent Developments
  61. 8.11 Bayer AG
  62. 8.11.1 Bayer AG Company Information
  63. 8.11.2 Bayer AG Business Overview
  64. 8.11.3 Bayer AG Drug Delivery Devices Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Bayer AG Drug Delivery Devices Product Portfolio
  66. 8.11.5 Bayer AG Recent Developments
  67. 8.12 Chiesi
  68. 8.12.1 Chiesi Company Information
  69. 8.12.2 Chiesi Business Overview
  70. 8.12.3 Chiesi Drug Delivery Devices Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Chiesi Drug Delivery Devices Product Portfolio
  72. 8.12.5 Chiesi Recent Developments
  73. 8.13 Phillips-Medisize
  74. 8.13.1 Phillips-Medisize Company Information
  75. 8.13.2 Phillips-Medisize Business Overview
  76. 8.13.3 Phillips-Medisize Drug Delivery Devices Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Phillips-Medisize Drug Delivery Devices Product Portfolio
  78. 8.13.5 Phillips-Medisize Recent Developments
  79. 8.14 Johnson & Johnson
  80. 8.14.1 Johnson & Johnson Company Information
  81. 8.14.2 Johnson & Johnson Business Overview
  82. 8.14.3 Johnson & Johnson Drug Delivery Devices Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Johnson & Johnson Drug Delivery Devices Product Portfolio
  84. 8.14.5 Johnson & Johnson Recent Developments
  85. 8.15 Shandong Weigao
  86. 8.15.1 Shandong Weigao Company Information
  87. 8.15.2 Shandong Weigao Business Overview
  88. 8.15.3 Shandong Weigao Drug Delivery Devices Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Shandong Weigao Drug Delivery Devices Product Portfolio
  90. 8.15.5 Shandong Weigao Recent Developments
  91. 8.16 Pfizer
  92. 8.16.1 Pfizer Company Information
  93. 8.16.2 Pfizer Business Overview
  94. 8.16.3 Pfizer Drug Delivery Devices Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Pfizer Drug Delivery Devices Product Portfolio
  96. 8.16.5 Pfizer Recent Developments
  97. 8.17 B.Braun
  98. 8.17.1 B.Braun Company Information
  99. 8.17.2 B.Braun Business Overview
  100. 8.17.3 B.Braun Drug Delivery Devices Revenue and Gross Margin (2021-2026)
  101. 8.17.4 B.Braun Drug Delivery Devices Product Portfolio
  102. 8.17.5 B.Braun Recent Developments
  103. 8.18 Novartis AG
  104. 8.18.1 Novartis AG Company Information
  105. 8.18.2 Novartis AG Business Overview
  106. 8.18.3 Novartis AG Drug Delivery Devices Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Novartis AG Drug Delivery Devices Product Portfolio
  108. 8.18.5 Novartis AG Recent Developments
  109. 8.19 Zhengkang
  110. 8.19.1 Zhengkang Company Information
  111. 8.19.2 Zhengkang Business Overview
  112. 8.19.3 Zhengkang Drug Delivery Devices Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Zhengkang Drug Delivery Devices Product Portfolio
  114. 8.19.5 Zhengkang Recent Developments
  115. 8.20 Gerresheimer
  116. 8.20.1 Gerresheimer Company Information
  117. 8.20.2 Gerresheimer Business Overview
  118. 8.20.3 Gerresheimer Drug Delivery Devices Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Gerresheimer Drug Delivery Devices Product Portfolio
  120. 8.20.5 Gerresheimer Recent Developments
  121. 8.21 COVIDIEN Medtronic
  122. 8.21.1 COVIDIEN Medtronic Company Information
  123. 8.21.2 COVIDIEN Medtronic Business Overview
  124. 8.21.3 COVIDIEN Medtronic Drug Delivery Devices Revenue and Gross Margin (2021-2026)
  125. 8.21.4 COVIDIEN Medtronic Drug Delivery Devices Product Portfolio
  126. 8.21.5 COVIDIEN Medtronic Recent Developments
  127. 8.22 Schott forma vitrum
  128. 8.22.1 Schott forma vitrum Company Information
  129. 8.22.2 Schott forma vitrum Business Overview
  130. 8.22.3 Schott forma vitrum Drug Delivery Devices Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Schott forma vitrum Drug Delivery Devices Product Portfolio
  132. 8.22.5 Schott forma vitrum Recent Developments
  133. 8.23 Alkermes
  134. 8.23.1 Alkermes Company Information
  135. 8.23.2 Alkermes Business Overview
  136. 8.23.3 Alkermes Drug Delivery Devices Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Alkermes Drug Delivery Devices Product Portfolio
  138. 8.23.5 Alkermes Recent Developments
  139. 8.24 Skyepharma
  140. 8.24.1 Skyepharma Company Information
  141. 8.24.2 Skyepharma Business Overview
  142. 8.24.3 Skyepharma Drug Delivery Devices Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Skyepharma Drug Delivery Devices Product Portfolio
  144. 8.24.5 Skyepharma Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst